Moreover, Dong et al. revealed that in tumor-associated macrophages (TAMs) of CRC, knockout of METTL14 results in a decrease in m6A levels, an increase in EBI3, and dysfunction of antitumor T cells, which then promots the malignant progression of tumors [86]. This evidence concerns the gene METTL14 and neoplasm.